methysergide has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boja, JW; Crisp, T; Schechter, MD; Stafinsky, JL | 1 |
| Gold, LH; Koob, GF | 1 |
| Fischer, HS; Humpel, C; Saria, A; Schatz, DS; Zernig, G | 1 |
| Colado, MI; Elliott, JM; Esteban, B; Green, AR; Mechan, AO; O'Shea, E | 1 |
| Colado, MI; Elliott, JM; Green, AR; O'shea, E; Saadat, KS | 1 |
| Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH | 1 |
1 review(s) available for methysergide and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Drug-induced fibrotic valvular heart disease.
Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents | 2009 |
5 other study(ies) available for methysergide and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Analgesics; Animals; Dose-Response Relationship, Drug; Male; Methysergide; Morphine; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Pain; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1989 |
Methysergide potentiates the hyperactivity produced by MDMA in rats.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Drug Synergism; Male; Methysergide; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1988 |
MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum.
Topics: Acetylcholine; Animals; Antiparkinson Agents; Corpus Striatum; Diphenhydramine; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Histamine H1 Antagonists; In Vitro Techniques; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Pyrilamine; Quinoxalines; Rats; Rats, Sprague-Dawley; Serotonin Agents; Serotonin Antagonists; Tritium | 2000 |
The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
Topics: 3,4-Methylenedioxyamphetamine; Acute Disease; Animals; Benzazepines; Body Temperature; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Fever; Hallucinogens; Hippocampus; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Neuroprotective Agents; Piperazines; Piperidines; Rats; Rats, Inbred Strains; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Remoxipride; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2002 |
The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Biogenic Monoamines; Body Temperature Regulation; Brain Chemistry; Fenclonine; Fever; Hot Temperature; Housing, Animal; Male; Methysergide; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Pyridines; Rats; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2005 |